Drug Dosing in Obesity

Dr Syed Tabish R. Zaidi is an experienced clinical pharmacist with special interest in Infectious Diseases and Translational Research. Dr. Zaidi is the course coordinator of postgraduate clinical pharmacy coursework at the University of Tasmania. He has a special interest in obesity research and currently supervising graduate students on examining medication use in obese patients within Australian hospitals. He is also leading several practice-based research projects in Australia, France and Middle East.       Professor Jason Roberts is a NHMRC Research Fellow at The University of Queensland, Consultant Clinical Pharmacist at the Royal Brisbane and Women’s Hospital and Adjunct Professor with Queensland University of Technology. He is a clinician-scientist with a strong interest in research and his principal research theme is optimization of antibiotic dosing in the critically ill. Prof Roberts has published over 250 published papers and book chapters on this topic, has been awarded over $20 million in grants and supervises 16 higher research degree students.

“With rising populations of obese patients and issues regarding antimicrobial resistance, this book is well timed. … Chapters end with a thorough reference list. Summary tables act as a quick reference point for readers. … ­ This comprehensive book is well structured, easy to use and has a wealth of useful information. It will be of particular value to those involved in managing obese patients with infections.” (Preet Panesar, British Journal of Hospital Medicine, Vol. 78 (4), April, 2017)

• Betalactams: Penicillins.- Betalactams: Cephalosporins.- Aminoglycosides.- Quinolones.- Carbapenems.- Glycopeptides and antibiotics for Gram-Positive Bacterial Infections.- Azole antifungals.- Echinocandins antifungals.- Polyene antifungals.- Miscellaneous antimicrobials.